HIGHLIGHTS
- who: Shams Tabrez and colleagues from the King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia have published the research work: Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression, in the Journal: Molecules 2022, 5042 of /2022/
- what: The authors report 12 potent compounds after screening the TCM database against GLS followed by a drug-likeness filter with Lipinski and Veber rule criteria.
SUMMARY
GLS activity corresponds with poor clinical prognosis in patients with breast, colorectal, lung, liver, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.